1
|
Turner K and Hameed AB: Hypertensive
disorders in pregnancy current practice review. Curr Hypertens Rev.
13:80–88. 2017.PubMed/NCBI
|
2
|
Mol BWJ, Roberts CT, Thangaratinam S,
Magee LA, de Groot CJM and Hofmeyr GJ: Pre-eclampsia. Lancet.
387:999–1011. 2016. View Article : Google Scholar
|
3
|
von Dadelszen P and Magee LA:
Pre-eclampsia: An update. Curr Hypertens Rep. 16:4542014.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Zakiyah N, Postma MJ, Baker PN and van
Asselt AD; IMPROvED Consortium: Pre-eclampsia diagnosis and
treatment options: A review of published economic assessments.
Pharmacoeconomics. 33:1069–1082. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Robins JC: Implantation:
Trophoblast-endometrial interactions. Semin Reprod Med. 34:3–4.
2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gupta SK, Malhotra SS, Malik A, Verma S
and Chaudhary P: Cell signaling pathways involved during invasion
and syncytialization of trophoblast cells. Am J Reprod Immunol.
75:361–371. 2016. View Article : Google Scholar
|
7
|
McNally R, Alqudah A, Obradovic D and
McClements L: Elucidating the pathogenesis of pre-eclampsia using
in vitro models of spiral uterine artery remodelling. Curr
Hypertens Rep. 19:932017. View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhang Y, Hu X, Gao G, Wang Y, Chen P and
Ye Y: Autophagy protects against oxidized low density
lipoprotein-mediated inflammation associated with preeclampsia.
Placenta. 48:136–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Arifin R, Kyi WM, Che Yaakob CA and Yaacob
NM: Increased circulating oxidised low-density lipoprotein and
antibodies to oxidised low-density lipoprotein in preeclampsia. J
Obstet Gynaecol. 37:580–584. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Liu CC, Prior J, Piwnica-Worms D and Bu G:
LRP6 overexpression defines a class of breast cancer subtype and is
a target for therapy. Proc Natl Acad Sci USA. 107:5136–5141. 2010.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Ramos JGL, Sass N and Costa SHM:
Preeclampsia. Rev Bras Ginecol Obstet. 39:496–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2^(-delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
13
|
Godbole G, Suman P, Malik A, Galvankar M,
Joshi N, Fazleabas A, Gupta SK and Modi D: Decrease in expression
of HOXA10 in the decidua after embryo implantation promotes
trophoblast invasion. Endocrinology. 158:2618–2633. 2017.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Li P, Guo W, Du L, Zhao J, Wang Y, Liu L,
Hu Y and Hou Y: microRNA-29b contributes to pre-eclampsia through
its effects on apoptosis, invasion and angiogenesis of trophoblast
cells. Clin Sci (Lond). 124:27–40. 2013. View Article : Google Scholar
|
15
|
Chen H, Meng T, Liu X, Sun M, Tong C, Liu
J, Wang H and Du J: Long non-coding RNA MALAT-1 is downregulated in
preeclampsia and regulates proliferation, apoptosis, migration and
invasion of JEG-3 trophoblast cells. Int J Clin Exp Pathol.
8:12718–12727. 2015.
|
16
|
Wang J, Wang X, Li Z, Liu H and Teng Y:
MicroRNA-183 suppresses retinoblastoma cell growth, invasion and
migration by targeting LRP6. FEBS J. 281:1355–1365. 2014.
View Article : Google Scholar
|
17
|
Mao Z, Li H, Du B, Cui K, Xing Y, Zhao X
and Zai S: LncRNA DANCR promotes migration and invasion through
suppression of lncRNA-LET in gastric cancer cells. Biosci Rep.
37:BSR201710702017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yao Q, An Y, Hou W, Cao YN, Yao MF, Ma NN,
Hou L, Zhang H, Liu HJ and Zhang B: LRP6 promotes invasion and
metastasis of colorectal cancer through cytoskeleton dynamics.
Oncotarget. 8:109632–109645. 2017. View Article : Google Scholar
|
19
|
Zhong T, Chen J, Ling Y, Yang B, Xie X, Yu
D, Zhang D, Ouyang J and Kuang H: Down-regulation of neuropathy
target esterase in preeclampsia placenta inhibits human trophoblast
cell invasion via modulating MMP-9 levels. Cell Physiol Biochem.
45:1013–1022. 2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Arpino V, Brock M and Gill SE: The role of
TIMPs in regulation of extracellular matrix proteolysis. Matrix
Biol. 44-46:247–254. 2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zong L, Wei X, Gou W, Huang P and Lv Y:
Zinc improves learning and memory abilities of fetal growth
restriction rats and promotes trophoblast cell invasion and
migration via enhancing STAT3-MMP-2/9 axis activity. Oncotarget.
8:115190–115201. 2017. View Article : Google Scholar
|
22
|
Yu Y, Wang L, Liu T and Guan H:
MicroRNA-204 suppresses trophoblast-like cell invasion by targeting
matrix metallopro-teinase-9. Biochem Biophys Res Commun.
463:285–291. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Nissi R, Talvensaari-Mattila A, Kotila V,
Niinimaki M, Jarvela I and Turpeenniemi-Hujanen T: Circulating
matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are
associated with spontaneous early pregnancy failure. Reprod Biol
Endocrinol. 11:22013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Zendjabil M, Favard S, Tse C, Abbou O and
Hainque B: The microRNAs as biomarkers: What prospects? C R Biol.
340:114–131. 2017.In French. View Article : Google Scholar : PubMed/NCBI
|
25
|
Liang J, Wang S and Wang Z: Role of
microRNAs in embryo implantation. Reprod Biol Endocrinol.
15:902017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tufekci KU, Oner MG, Meuwissen RL and Genc
S: The role of microRNAs in human diseases. Methods Mol Biol.
1107:33–50. 2014. View Article : Google Scholar
|
27
|
Yu Q, Yang X, Duan W, Li C, Luo Y and Lu
S: miRNA-346 promotes proliferation, migration and invasion in
liver cancer. Oncol Lett. 14:3255–3260. 2017. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yan HL, Li L, Li SJ, Zhang HS and Xu W:
miR-346 promotes migration and invasion of nasopharyngeal carcinoma
cells via targeting BRMS1. J Biochem Mol Toxicol. 30:602–607. 2016.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Yang F, Luo LJ, Zhang L, Wang DD, Yang SJ,
Ding L, Li J, Chen D, Ma R, Wu JZ and Tang JH: MiR-346 promotes the
biological function of breast cancer cells by targeting SRCIN1 and
reduces chemosensitivity to docetaxel. Gene. 600:21–28. 2017.
View Article : Google Scholar
|
30
|
Su MT, Tsai PY, Tsai HL, Chen YC and Kuo
PL: miR-346 and miR-582-3p-regulated EG-VEGF expression and
trophoblast invasion via matrix metalloproteinases 2-9. Biofactors.
43:210–219. 2017. View Article : Google Scholar
|